-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
An interview with Professor Heather Wilson-Robles regarding NEW data presented at the VCS Conference 2021
- Share
- Tweet
- Share on Facebook
- Share
Professor Heather Wilson-Robles, Chief Medical Officer of Volition Veterinary, discusses two new data presentations from the 2021 VCS virtual conference.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields